Sign up to save your podcasts
Or
Share Why ICIs Have Revolutionized Cancer Care
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Why ICIs Have Revolutionized Cancer Care
Host: Patrick Forde, M.B.B.Ch.
Guest: Jesús García-Foncillas, MD, PHD
Immune checkpoint inhibitors, or ICIs, have improved the prognosis for patients with many different types of cancer. Drs. Forde and García-Foncillas outline current biomarkers and the importance of testing to optimize patient outcomes. Your patients will thank you for tuning in!
View all episodes
By ReachMD
4.5
22 ratings
Host: Patrick Forde, M.B.B.Ch.
Guest: Jesús García-Foncillas, MD, PHD
Immune checkpoint inhibitors, or ICIs, have improved the prognosis for patients with many different types of cancer. Drs. Forde and García-Foncillas outline current biomarkers and the importance of testing to optimize patient outcomes. Your patients will thank you for tuning in!
More shows like Project Oncology®
View all
Journal of Clinical Oncology (JCO) Podcast
39 Listeners
PeerView Oncology & Hematology CME/CNE/CPE Video Podcast
10 Listeners
ASCO Daily News
59 Listeners
Core IM | Internal Medicine Podcast
1,145 Listeners
Two Onc Docs
195 Listeners
Oncology Brothers: Practice-Changing Cancer Discussions
45 Listeners
CME in Minutes: Education in Oncology & Hematology
7 Listeners